| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-03-22 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 1,535,685 | 50.3% | EDGAR |
| SC 13D | 2024-03-05 | BAKER BROS. ADVISORS LP | vTv Therapeutics Inc. | 122,664 | 5.0% | EDGAR |
| SC 13D | 2024-03-05 | Samsara BioCapital, L.P. | vTv Therapeutics Inc. | 265,620 | 10.4% | EDGAR |
| SC 13G | 2022-08-23 | Medpace Investors, LLC | vTv Therapeutics Inc. | 5,397,529 | 5.2% | EDGAR |
| SC 13D | 2022-06-10 | G42 Investments AI Holdings RSC Ltd. | vTv Therapeutics Inc. | 10,386,274 | 13.4% | EDGAR |
| SC 13D/A | 2022-06-01 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 61,427,396 | 60.1% | EDGAR |
| SC 13D/A | 2021-11-12 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 61,514,396 | 67.0% | EDGAR |
| SC 13D/A | 2021-09-17 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 61,514,396 | 72.3% | EDGAR |
| SC 13D/A | 2020-12-17 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 61,514,396 | 79.3% | EDGAR |
| SC 13D/A | 2020-12-10 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 61,514,396 | 79.3% | EDGAR |
| SC 13D/A | 2020-11-24 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 61,514,396 | 79.3% | EDGAR |
| SC 13D/A | 2020-05-12 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 61,514,396 | 85.3% | EDGAR |
| SC 13D/A | 2020-02-25 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 61,514,396 | 85.3% | EDGAR |
| SC 13D/A | 2020-01-28 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 61,514,396 | 85.3% | EDGAR |
| SC 13D/A | 2020-01-07 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 61,514,396 | 85.3% | EDGAR |
| SC 13D/A | 2019-12-23 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 61,514,396 | 85.3% | EDGAR |
| SC 13D/A | 2019-12-18 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 54,898,924 | 83.9% | EDGAR |
| SC 13D/A | 2019-11-26 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 54,898,924 | 83.9% | EDGAR |
| SC 13D/A | 2019-11-12 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 54,898,924 | 83.9% | EDGAR |
| SC 13D/A | 2019-10-25 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 54,898,924 | 83.9% | EDGAR |